Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for anesthesia in radical colorectal cancer surgery
ChiCTR2300068931Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in colorectal cancer (CRC) (2 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoint: Immune function. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2300068931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068931.